Theralase Technologies Stock Price on December 13, 2024
| TLT Stock | CAD 0.26 0.01 3.70% |
Below is the normalized historical share price chart for Theralase Technologies extending back to August 20, 2003. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Theralase Technologies stands at 0.26, as last reported on the 14th of December 2024, with the highest price reaching 0.26 and the lowest price hitting 0.25 during the day.
If you're considering investing in Theralase Stock, it is important to understand the factors that can impact its price. Theralase Technologies is out of control given 3 months investment horizon. Theralase Technologies owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0915, which indicates the firm had a 0.0915% return per unit of risk over the last 3 months. We were able to interpolate twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.31% are justified by taking the suggested risk. Use Theralase Technologies Coefficient Of Variation of 1037.37, semi deviation of 6.57, and Risk Adjusted Performance of 0.0794 to evaluate company specific risk that cannot be diversified away.
At this time, Theralase Technologies' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to climb to about 231 M in 2024, whereas Common Stock is likely to drop slightly above 29.7 M in 2024. . Price Earnings To Growth Ratio is likely to climb to 0.52 in 2024, whereas Price To Sales Ratio is likely to drop 35.14 in 2024. Theralase Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.1916 | 50 Day MA 0.2176 | Beta 1.349 |
Theralase |
Sharpe Ratio = 0.0915
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | TLT | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 14.31 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.31 actual daily | 26 74% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Theralase Technologies is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theralase Technologies by adding it to a well-diversified portfolio.
Price Book 29.5394 | Enterprise Value Ebitda (12.06) | Price Sales 71.3233 | Shares Float 226 M | Wall Street Target Price 1.2 |
Theralase Technologies Valuation on December 13, 2024
It is possible to determine the worth of Theralase Technologies on a given historical date. On December 13, 2024 Theralase was worth 0.26 at the beginning of the trading date compared to the closed value of 0.26. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Theralase Technologies stock. Still, in general, we apply an absolute valuation method to find Theralase Technologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Theralase Technologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Theralase Technologies' related companies.
| Open | High | Low | Close | Volume | |
| 0.26 | 0.27 | 0.25 | 0.26 | 20,290 | |
12/13/2024 | 0.26 | 0.26 | 0.25 | 0.26 | 58,673 |
| Backtest Theralase Technologies | | | Theralase Technologies History | | | Theralase Technologies Valuation | Previous |
Theralase Technologies Trading Date Momentum on December 13, 2024
| On December 13 2024 Theralase Technologies was traded for 0.26 at the closing time. The highest daily price throughout the period was 0.26 and the lowest price was 0.25 . The daily volume was 58.7 K. The net trading volume on 12/13/2024 did not result in any price rise and fall. The trading price change to current closing price is 0.00% . |
Theralase Technologies Fundamentals Correlations and Trends
By evaluating Theralase Technologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Theralase Technologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Theralase financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Theralase Technologies Stock history
Theralase Technologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Theralase is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Theralase Technologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Theralase Technologies stock prices may prove useful in developing a viable investing in Theralase Technologies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 220 M | 231 M | |
| Net Loss | -4.7 M | -4.9 M |
Theralase Technologies Quarterly Net Working Capital |
|
Theralase Technologies Stock Technical Analysis
Theralase Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Theralase Technologies Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
Theralase Technologies cannot be verified against its exchange. Please verify the symbol is currently traded on TSX Venture Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Theralase Technologies December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how Theralase Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Theralase Technologies shares will generate the highest return on investment. By undertsting and applying Theralase Technologies stock market strength indicators, traders can identify Theralase Technologies entry and exit signals to maximize returns
Theralase Technologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Theralase Technologies' price direction in advance. Along with the technical and fundamental analysis of Theralase Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Theralase to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0794 | |||
| Jensen Alpha | 1.26 | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.1138 | |||
| Treynor Ratio | 1.4 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.